(Reuters) – Drugmaker Novartis AG said on Monday is has acquired MorphoSys AG, a developer of cancer treatments, for 2.7 billion euros. ($2.90 billion)
($1 = 0.9312 euros)
(Reporting by Urvi Dugar in Bengaluru; Editing by Shilpi Majumdar)
(Reuters) – Drugmaker Novartis AG said on Monday is has acquired MorphoSys AG, a developer of cancer treatments, for 2.7 billion euros. ($2.90 billion)
($1 = 0.9312 euros)
(Reporting by Urvi Dugar in Bengaluru; Editing by Shilpi Majumdar)
Comments